EUVIMEDDescubrir EUVIMED
Open access · CC BY 4.0

The E2F1–HOXB9 / PBX2–CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer

Jinglin Zhang, Bonan Chen, Yifei Wang, Xiaoli Liu, Huan Yan, Kit Yee Wong, Aden Ky Chan iD, Alvin Hk Cheung, Chit Chow, Dazhi Xu, Shouyu Wang, Bing Huang and 9 more

The Journal of Pathology · 2023

DOI: 10.1002/path.6091 ↗

At a glance

Journal article in The Journal of Pathology, 2023. Written by Jinglin Zhang and 20 co-authors. Institution: Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir YK Pao Cancer Center, The Chinese University of …. Major MEDLINE topics: Stomach Neoplasms. Cited 13 times so far (Crossref); 55 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Homeobox genes include HOX and non ‐HOX genes. HOX proteins play fundamental roles during ontogenesis by interacting with other non‐ HOX gene‐encoded partners and performing transcriptional functions, whereas aberrant activation of HOX family members drives tumorigenesis. In this study, gastric cancer (GC) expression microarray data indicated that HOXB9 is a prominent upregulated HOX member in GC samples significantly associated with clinical outcomes and advanced TNM stages. However, the functional role of HOXB9 in GC remains contradictory in previous reports, and the regulatory mechanisms are elusive. By in silico and experimental analyses, we found that HOXB9 was upregulated by a vital cell cycle‐related transcription factor, E2F1. Depleting HOXB9 causes G1‐phase cell cycle arrest by downregulating CDK6 and a subset of cell cycle‐related genes. Meanwhile, HOXB9 contributes to cell division and maintains the cytoskeleton in GC cells. We verified that HOXB9 interacts with PBX2 to form a heterodimer, which transcriptionally upregulates CDK6 . Knocking down CDK6 can phenocopy the tumor‐suppressive effects caused by HOXB9 depletion. Blocking HOXB9 can enhance the anti‐tumor effect of CDK6 inhibitors. In conclusion, we elucidate the oncogenic role of HOXB9 in GC and reveal CDK6 as its potent downstream effector. The E2F1–HOXB9/PBX2–CDK6 axis represents a novel mechanism driving gastric carcinogenesis and conveys prognostic and therapeutic implications. © 2023 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Stomach NeoplasmsHumansGenes, HomeoboxCell Line, TumorCarcinogenesisTranscription FactorsCell Transformation, NeoplasticHomeodomain ProteinsGene Expression Regulation, NeoplasticCell ProliferationProto-Oncogene ProteinsE2F1 Transcription FactorCyclin-Dependent Kinase 6

Author keywords

CDK6E2F1HOXB9PBX2cell cyclegastric cancer

Substances

Transcription FactorsHomeodomain ProteinsProto-Oncogene ProteinsE2F1 Transcription FactorPBX2 protein, humanHOXB9 protein, humanE2F1 protein, humanCDK6 protein, humanCyclin-Dependent Kinase 6

Authors and institutions

  • Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir YK Pao Cancer Center, The Chinese University of Hong Kong, Hong Kong SAR, PR China.
  • Institute of Digestive Disease, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, Hong Kong SAR, PR China.
  • CUHK-Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, PR China.
  • Department of Gastric Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, PR China.
  • Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, PR China.
  • Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, PR China.

ORCID profiles: Aden Ky Chan, Li Liang, William Kk Wu, Jun Yu, Kwok Wai Lo, Wei Kang

Funding

  • National Natural Science Foundation of China

Cite

APA

Zhang, J., Chen, B., Wang, Y., Liu, X., Yan, H., Wong, K. Y., Chan, A. K., Cheung, A. H., Chow, C., Xu, D., Wang, S., Huang, B., Liang, L., Ke, H., Wong, C. C., Wu, W. K., Cheng, A. S., Yu, J., Lo, K. W., …, & Kang, W. (2023). The E2F1–HOXB9 / PBX2–CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer. The Journal of Pathology. https://doi.org/10.1002/path.6091

Vancouver

Zhang J, Chen B, Wang Y, Liu X, Yan H, Wong KY, et al. The E2F1–HOXB9 / PBX2–CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer. The Journal of Pathology. 2023. doi:10.1002/path.6091

BibTeX
@article{Zhang2023,
  author = {Zhang, Jinglin and Chen, Bonan and Wang, Yifei and Liu, Xiaoli and Yan, Huan and Wong, Kit Yee and Chan, Aden Ky and Cheung, Alvin Hk and Chow, Chit and Xu, Dazhi and Wang, Shouyu and Huang, Bing and Liang, Li and Ke, Huixing and Wong, Chi Chun and Wu, William Kk and Cheng, Alfred Sl and Yu, Jun and Lo, Kwok Wai and To, Ka Fai and Kang, Wei},
  title = {The E2F1–HOXB9 / PBX2–CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer},
  journal = {The Journal of Pathology},
  year = {2023},
  doi = {10.1002/path.6091}
}
Start for free →